CNBC: Many employers drop GLP-1 weight-loss drug coverage as premiums soar, ahead of 2027 open enrollment
Key points
- Many employers are dropping GLP-1 weight-loss drug coverage or reducing payouts as premiums rise
- Some employers are shifting to third-party weight management programs
- Coverage reportedly costs mid-$500s to mid-$600s per user monthly; Bank of America says it spends about $250 million or more a year
CNBC reported that many employer-sponsored health plans are dropping GLP-1 weight-loss drug coverage or offering less generous payouts as premiums soar, with some shifting to third-party weight management programs. Coverage typically costs in the mid-$500s to mid-$600s per user monthly. Bank of America's CEO said the bank spends about $250 million or more on GLP-1 drugs each year.
Tip: Employers can review current GLP-1 coverage in their benefits plans and communicate any changes to employees before 2027 open enrollment.
What employers should do
- Tip: Review current GLP-1 coverage and communicate changes before 2027 open enrollment
Original report: CNBC ↗Edited with AI assistance. Facts are based on official sources and original reports. For information only; not legal, immigration or insurance advice.